1. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics;Schwarzinger M;Lancet Public Health,2021
2. FDA. Pfizer-BioNTech COVID-19 vaccine emergency use authorization review memorandum. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration. (2020). Accessed: May 1, 2022: https://www.fda.gov/media/144416/download.
3. FDA. Pfizer-BioNTech COVID-19 vaccine EUA amendment review memorandum. Silver Spring, MD: US Department of Health and Human Services. (2021). Accessed: May 1, 2022: https://fda.report/media/149528/nr_EUA+27034.132+Review+Memo+Pfizer-BioNTech+COVID-19+Vaccine_REVISED24May_final.pdf.
4. COVID-19 vaccine safety in adolescents aged 12-17 years: United States, December 14, 2020-July 16, 2021;Hause AM;MMWR Morb Mortal Wkly Rep,2021
5. Weaver J. Moderna files for FDA authorization for Covid vaccine in younger teens, adolescents. NBC News. (2021). Accessed: February 1, 2022: https://www.nbcnews.com/health/kids-health/moderna-files-authorization-covid-vaccine-younger-teens-adolescents-n12702....